Physician

Justin D Floyd, DO

According to 2025 Medicare claims, Justin Floyd, DO (NPI: 1629164678) practices hematology/oncology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Clinton, IL. This provider's primary affiliated billing organization is CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (NPI: 1871580142; TIN: 371160364) and primary practice location at 62269-1887. Floyd is affiliated with the IRCCO (ACO ID: A2619), IHCI ACO Midwest LLC (ACO ID: A5516), and Quality Health Partners, LLC (ACO ID: A5553), participating under the MSSP model.

Floyd's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 522 traditional Medicare patients, billed 230,974 HCPCS/CPT codes, and received $3,721,197 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,825 prescription claims across 290 beneficiaries totaling $5,013,736 in drug costs, led by Ibrance (Palbociclib). DME data shows 11 claims. Open Payments data shows 78 records totaling $2,164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $88,487 to $3,721,197. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,488,650 to $5,013,736. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	409	3,818	$88,487
2016	224	33,046	$306,720
2017	437	99,766	$1,118,318
2018	416	106,449	$1,508,003
2019	477	151,223	$2,243,201
2020	512	171,091	$2,931,745
2021	563	220,605	$3,106,771
2022	506	244,053	$3,729,985
2023	502	249,756	$3,682,517
2024	522	230,974	$3,721,197

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	152	967	$1,488,650
2016	91	530	$671,082
2017	155	957	$1,375,942
2018	168	1,096	$1,694,951
2019	194	1,280	$2,654,911
2020	216	1,717	$3,385,287
2021	235	1,407	$3,974,857
2022	219	1,384	$3,547,485
2023	226	1,452	$3,134,641
2024	290	1,825	$5,013,736

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	131	$42,840
2016	N/R	55	$12,742
2017	N/R	22	$2,002
2018	24	164	$20,216
2019	N/R	119	$14,136
2020	11	95	$7,155
2021	N/R	108	$5,522
2022	12	117	$3,316
2023	N/R	93	$8,442
2024	N/R	11	$1,396

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	360	1,484	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	189	262	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	320	720	$13
80053	Blood test, comprehensive group of blood chemicals	224	1,041	$10
36415	Insertion of needle into vein for collection of blood sample	349	1,143	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	35	980	$560,223
Lenalidomide	Lenalidomide	35	973	$552,122
Xtandi	Enzalutamide	37	1,110	$533,809
Cabometyx	Cabozantinib S-Malate	15	450	$385,503
Pomalyst	Pomalidomide	18	504	$362,911

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4428	Ostomy pouch, urinary, with extended wear barrier attached, with faucet-type tap with valve (1 piece), each	N	N/R	11	$1,396

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	78	$2,164	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Justin D. Floyd, DO?

Tedicare shows public-source Medicare data for Justin D. Floyd, DO (NPI 1629164678), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Justin D. Floyd, DO have ACO affiliation data?

Justin D. Floyd, DO is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619), IHCI ACO Midwest LLC (MSSP, ACO ID A5516), and Quality Health Partners, LLC (MSSP, ACO ID A5553).

What billing organization is linked to Justin D. Floyd, DO?

Justin D. Floyd, DO is linked to CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (billing NPI 1871580142) in the available physician profile data.

Does Justin D. Floyd, DO have Open Payments data?

Justin D. Floyd, DO has 78 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.